AI Startup Lifescience Dynamics Speeds up Drug Development with Data and Insights for Pharma Giants
-
Pharmaceutical companies rely on third-party research firms like Lifescience Dynamics for data, insights, and recommendations to speed up drug development and FDA approval.
-
Lifescience Dynamics uses AI, including machine learning and generative models, to collect, analyze, and visualize data for pharmaceutical clients.
-
AI has helped automate previously manual tasks like tracking clinical trials, scraping medical conference info, building physician surveys.
-
The major challenge is lack of shareable industry data due to privacy and competitiveness; more data would allow more powerful AI models.
-
Some industry leaders doubt AI's promise, but Lifescience Dynamics sees AI as a key tool to provide clients foresight and decision-making support.